Actively Recruiting
Pre-pectoral Breast Reconstruction With or Without Mesh
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2024-01-31
164
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.
CONDITIONS
Official Title
Pre-pectoral Breast Reconstruction With or Without Mesh
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult women aged 18-65 years planning unilateral or bilateral immediate prepectoral prosthesis breast reconstruction
- Undergoing skin-sparing, nipple-sparing, or skin-reducing mastectomy for breast cancer or prophylactic mastectomy
- Tissue expander size less than or equal to 800cc, implant size less than or equal to 600cc
- Good blood perfusion of the breast skin flap
- Non-smoker for at least 4 weeks prior to surgery
- Normal expectations and mental health regarding breast reconstruction
- Signed consent to participate
You will not qualify if you...
- Poor perfusion of breast mastectomy flap
- Patients undergoing second stage breast reconstruction
- History of chest radiotherapy
- Body mass index (BMI) greater than 35
- Smoking within the last 4 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China, 300060
Actively Recruiting
Research Team
J
Jian Yin
CONTACT
C
Chunyong Han
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here